Edwards Lifesciences Corporation (EW)
NYSE: EW · Real-Time Price · USD
69.90
+2.83 (4.22%)
At close: Apr 9, 2025, 4:00 PM
68.89
-1.01 (-1.45%)
Pre-market: Apr 10, 2025, 4:22 AM EDT
Edwards Lifesciences Analyst Ratings
Total Analysts
21
Consensus Rating
Buy
Price Target
$79.95
Upside
+14.38%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Maintains $88 → $90 | Buy | Maintains | $88 → $90 | +28.76% | Feb 13, 2025 |
| Canaccord Genuity | Canaccord Genuity | Hold Maintains $68 → $71 | Hold | Maintains | $68 → $71 | +1.57% | Feb 13, 2025 |
| RBC Capital | RBC Capital | Buy Reiterates $85 | Buy | Reiterates | $85 | +21.60% | Feb 12, 2025 |
| Piper Sandler | Piper Sandler | Hold Maintains $70 → $73 | Hold | Maintains | $70 → $73 | +4.43% | Feb 12, 2025 |
| Evercore ISI Group | Evercore ISI Group | Hold Maintains $75 → $73 | Hold | Maintains | $75 → $73 | +4.43% | Feb 12, 2025 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $70 → $75 | Hold | Maintains | $70 → $75 | +7.30% | Feb 12, 2025 |
| Stifel | Stifel | Hold → Strong Buy Upgrades $75 → $90 | Hold → Strong Buy | Upgrades | $75 → $90 | +28.76% | Jan 30, 2025 |
| Wolfe Research | Wolfe Research | Hold → Sell Downgrades $60 | Hold → Sell | Downgrades | $60 | -14.16% | Jan 16, 2025 |
| B of A Securities | B of A Securities | Hold → Strong Buy Upgrades $82 → $90 | Hold → Strong Buy | Upgrades | $82 → $90 | +28.76% | Dec 16, 2024 |
| Citigroup | Citigroup | Strong Buy Maintains $81 → $83 | Strong Buy | Maintains | $81 → $83 | +18.74% | Dec 11, 2024 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $81 → $90 | Strong Buy | Maintains | $81 → $90 | +28.76% | Dec 5, 2024 |
| Truist Securities | Truist Securities | Hold Reiterates $70 → $78 | Hold | Reiterates | $70 → $78 | +11.59% | Dec 5, 2024 |
| Stifel | Stifel | Hold Maintains $70 → $75 | Hold | Maintains | $70 → $75 | +7.30% | Dec 5, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $80 → $85 | Buy | Maintains | $80 → $85 | +21.60% | Dec 5, 2024 |
| Canaccord Genuity | Canaccord Genuity | Hold Maintains $63 → $68 | Hold | Maintains | $63 → $68 | -2.72% | Dec 5, 2024 |
| Barclays | Barclays | Buy Maintains $85 → $88 | Buy | Maintains | $85 → $88 | +25.89% | Dec 2, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.